Physician profile
Christopher A End
NPI 1609072495
$4,378.60
in general payments reported to CMS, 2019-2025
35 companies · $543 in 2025
The $543 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $727 · 2020: $219 · 2021: $513 · 2022: $616 · 2023: $943 · 2024: $818 · 2025: $543.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,303.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,302.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $583.40 | 2019-2024 | Impella |
| Novartis Pharmaceuticals Corporation | $479.17 | 2019-2025 | |
| Shockwave Medical, INC | $423.59 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Amgen INC. | $352.34 | 2019-2025 | Repatha, Repatha |
| Pfizer INC. | $231.92 | 2019-2025 | |
| Actelion Pharmaceuticals US, INC. | $204.48 | 2019-2024 | Opsumit, Uptravi |
| Abbott Laboratories | $188.53 | 2019-2025 | Thoratec Heartmate 3 Lvas Implant Kit |
| E.R. Squibb & Sons, L.L.C. | $186.47 | 2022-2025 | Camzyos, Eliquis |
| Janssen Pharmaceuticals, INC | $168.11 | 2020-2024 | Xarelto |
| Heartflow, INC. | $162.18 | 2019-2025 | Ffrct |
| Boehringer Ingelheim Pharmaceuticals, INC. | $119.54 | 2019-2024 | Jardiance |
| Medtronic, INC. | $118.63 | 2022-2023 | Onyx Frontier |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $117.12 | 2019-2025 | Lifevest |
| Terumo Medical Corporation | $110.70 | 2023 | Metacross Otw, Glidewire, Heartrail |
| Acist Medical Systems, INC. | $109.14 | 2024 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $103.67 | 2022-2025 | Twin-Pass |
| Esperion Therapeutics, INC. | $94.95 | 2022-2025 | Nexletol |
| Irhythm Technologies, INC. | $93.02 | 2020-2024 | Zio Monitor, Zio Xt Patch |
| Cvrx, INC. | $70.26 | 2019-2023 | Barostim Neo System |
| Philips North America LLC | $62.19 | 2023-2024 | (Ck4) Mcot |
| Astrazeneca Pharmaceuticals Lp | $61.35 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $45.25 | 2023-2025 | |
| Portola Pharmaceuticals, LLC | $41.51 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $30.89 | 2019 | |
| Chiesi USA, INC. | $28.98 | 2020-2021 | |
| Sanofi-Aventis U.S. LLC | $27.93 | 2019-2024 | |
| Stryker Corporation | $24.86 | 2025 | Clottriever Bold Catheter |
| Zoll Circulation INC | $21.30 | 2025 | Downstream Cartridge, Catheter, Therox Ds2 Console |
| Elutia, INC. | $19.61 | 2022 | |
| Novo Nordisk INC | $18.63 | 2023 | Rybelsus, Ozempic |
| Merck Sharp & Dohme LLC | $17.78 | 2025 | Verquvo |
| Lexicon Pharmaceuticals, INC. | $16.77 | 2023 | Inpefa |
| Altathera Pharmaceuticals LLC | $15.05 | 2025 | Sotalol Hydrochloride |
| Amarin Pharma, INC. | $14.94 | 2020 | |
| Alnylam Pharmaceuticals INC. | $14.34 | 2025 | Onpattro |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher End listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.